What are the treatment options for psoriasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Psoriasis Treatment Options

The most effective approach to psoriasis treatment should be tailored based on disease severity, with topical therapies for mild disease (<5% body surface area), phototherapy for moderate disease, and systemic/biologic agents for severe disease or those with psoriatic arthritis. 1, 2

Disease Classification and Treatment Selection

  • Psoriasis severity is categorized as mild (typically <5% body surface area [BSA]) or moderate-to-severe (≥5% BSA or involvement of vulnerable areas) 1, 2
  • Patients with symptomatic psoriasis (pain, bleeding, itching) should be considered for systemic or phototherapy even if BSA involvement is limited 2
  • Quality of life impact should be considered when selecting therapy, as psychological distress can be significant regardless of physical extent 1, 2

Treatment Algorithm Based on Disease Severity

For Mild Psoriasis (<5% BSA)

  • First-line treatment includes topical therapies such as:
    • Topical corticosteroids (e.g., clobetasol propionate 0.05%, halobetasol propionate 0.05%) 3, 4
    • Vitamin D analogues (calcipotriene, calcitriol) 4
    • Combination products (corticosteroids plus vitamin D analogues) 4, 5
    • Coal tar preparations 3

For Moderate-to-Severe Psoriasis (≥5% BSA)

  • First-line treatment includes phototherapy:
    • Narrowband UVB 1, 2
    • PUVA (psoralen plus UVA) 1, 2
  • Second-line options include traditional systemic agents:
    • Methotrexate 3, 1, 2
    • Cyclosporine 3, 1, 2
    • Acitretin 3, 1, 2
  • Third-line options include biologic agents:
    • TNF inhibitors (e.g., adalimumab) 6
    • IL-17 inhibitors 1, 2
    • IL-23 inhibitors 1, 2
    • IL-12/23 inhibitors 3, 1

Special Considerations for Specific Psoriasis Types

Scalp Psoriasis

  • Calcipotriene foam or calcipotriene plus betamethasone dipropionate gel for 4-12 weeks 4, 2
  • Coal tar shampoos can be effective 3

Facial and Intertriginous Psoriasis

  • Low-potency corticosteroids are recommended to avoid skin atrophy 4, 2
  • Tacalcitol ointment or calcipotriene combined with hydrocortisone 4

Psoriatic Arthritis

  • For mild joint symptoms, NSAIDs are recommended 2
  • For moderate-to-severe joint involvement, DMARDs such as methotrexate are recommended 2
  • For inadequate response to at least one DMARD, TNF inhibitors like adalimumab are effective for both skin and joint symptoms 2, 6

Combination and Rotational Strategies

  • Combination therapy with topical corticosteroids plus vitamin D analogues enhances efficacy and reduces irritation 1, 5
  • Addition of topical agents to systemic therapies can improve outcomes:
    • Class 1 topical corticosteroids with etanercept 3
    • Calcipotriene/betamethasone with adalimumab 3
    • Topical calcipotriene with methotrexate 3
  • Rotational therapy (switching between treatment modalities every 1-2 years) may minimize cumulative toxicity of individual treatments 1

Common Pitfalls and Caveats

  • Systemic corticosteroids should be avoided in psoriasis as they can cause disease flare during taper 1, 2
  • Long-term use of potent topical corticosteroids can cause skin atrophy, striae, and telangiectasia 1, 2
  • Vitamin D analogues should be applied after phototherapy to avoid inactivation 1
  • Combination of multiple systemic agents may increase risk of toxicity 1
  • Commercial sunbeds are rarely effective for psoriasis and may cause premature skin aging and increased skin fragility 2
  • Drugs that may precipitate or worsen psoriasis include alcohol, beta-blockers, NSAIDs, lithium, chloroquine, and mepacrine 1

Alternative Medicine Approaches

  • Coal tar preparations are recommended for the treatment of mild to moderate psoriasis 3
  • Oral curcumin supplementation may benefit as adjunctive therapy 1
  • Mindfulness meditation and stress reduction techniques can improve psoriasis severity in some patients 1

Despite the wide range of available treatments, the goal should be to achieve clear or almost clear skin (≤1% BSA involvement) to maximize quality of life and minimize disease impact 5. The most recent guidelines emphasize the importance of treating to target and regularly reassessing treatment response 1, 2.

References

Guideline

Psoriasis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Psoriasis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Psoriasis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.